Get the latest news, insights, and market updates on CL (Colgate-Palmolive Company). Explore the news page 8 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Technicals Point to Buying Opportunity for Former Stock Picks
As markets rotate toward value, many of the old favorites investors once overlooked are quietly setting up as opportunities. Stocks that lagged the tech-driven rally of the past few years are showing constructive technical patterns and attractive relative strength, offering a second look from our picks last year. With the broader market favoring sectors like energy, industrials, and consumer staples, revisiting these prior picks can reveal opportunities where patience and timing may be rewarded. Jan 22, 2026 - $CL
Did Colgate-Palmolive’s (CL) WHO Oral Health Alliance Just Recast Its Sustainability Investment Narrative?
Colgate-Palmolive recently announced a four-year collaboration with the WHO Foundation to support the World Health Organization’s oral health initiatives, including education, integration into national health systems, and broader public awareness. This partnership underscores how a global consumer brand is aligning closely with public health priorities, potentially strengthening its profile on sustainability and social responsibility. We’ll now explore how this expanded WHO Foundation... Jan 21, 2026 - $CL
Colgate-Palmolive (CL) Valuation Check After Defensive Rotation And Upgraded Analyst Views
Recent commentary from Barclays and Wells Fargo has pushed Colgate-Palmolive (CL) into focus, as both banks highlight growing investor interest in the stock as a defensive option while maintaining a cautious stance on fundamentals. See our latest analysis for Colgate-Palmolive. The recent analyst comments and Colgate-Palmolive’s new four year collaboration with the WHO Foundation come as the shares trade at US$85.44. The 30 day share price return is 9.04% and the year to date share price... Jan 21, 2026 - $CL
1 Consumer Stock on Our Watchlist and 2 We Question
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. The flip side is that they frequently fall behind growth industries when times are good, and this perception became a reality over the past six months as the sector was down 4.5% while the S&P 500 was up 10%. Jan 21, 2026 - $CL
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health
NEW YORK, January 20, 2026--Today, Colgate-Palmolive announced a new multi-year collaboration with the WHO Foundation to support the World Health Organization's work on oral health. The four-year funding commitment will help expand oral health education, support integration of oral health into national health systems, and raise awareness of oral health as a public health priority. This initiative builds on Colgate’s commitment to providing communities with oral health education and resources. Th Jan 20, 2026 - $CL
Barclays Raises Colgate (CL) Target to $83 but Stays Cautious on Fundamentals
Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best Dividend Kings to Buy in 2026. On January 16, Barclays analyst Lauren Lieberman raised Barclays’ price target on Colgate-Palmolive Company (NYSE:CL) to $83 from $80 and kept an Equal Weight rating on the stock. The change came as part of the firm’s broader Q4 earnings preview […] Jan 20, 2026 - $CL
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple